Michel Rotily
Overview
Explore the profile of Michel Rotily including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rotily M, Vainchtock A, Jouaneton B, Wartelle-Bladou C, Abergel A
Clin Res Hepatol Gastroenterol
. 2013 Jan;
37(4):365-72.
PMID: 23273498
Aims: To evaluate the health care burden of chronic hepatitis C (CHC) in French hospitals. Methods: All hospital stays with CHC ICD-10 code were extracted from the 2009 French hospital...
12.
Marcellin P, Chousterman M, Fontanges T, Ouzan D, Rotily M, Varastet M, et al.
Liver Int
. 2011 Mar;
31(4):516-24.
PMID: 21382162
Background: Adherence is important for therapy of chronic diseases, but has still not been well studied in real life in chronic hepatitis C. Aims: To assess adherence to hepatitis C...
13.
Lang J, Melin P, Ouzan D, Rotily M, Fontanges T, Marcellin P, et al.
Antivir Ther
. 2010 Jul;
15(4):599-606.
PMID: 20587853
Background: Hepatitis C antiviral therapies have significant psychiatric side effects. It is therefore believed that they might exacerbate mental illness in patients with pre-existing psychiatric disorders, resulting in poor adherence...
14.
Melin P, Chousterman M, Fontanges T, Ouzan D, Rotily M, Lang J, et al.
Eur J Gastroenterol Hepatol
. 2010 Mar;
22(9):1050-7.
PMID: 20351554
Objective: Injection drug users are often excluded from hepatitis C virus (HCV) treatment. This study compares sustained virological response, adherence, and quality of life in patients with or without a...
15.
Marzo J, Rotily M, Meroueh F, Varastet M, Hunault C, Obradovic I, et al.
Addiction
. 2009 May;
104(7):1233-40.
PMID: 19426291
Aims: To describe the profile of imprisoned opioid-dependent patients, prescriptions of maintenance therapy at imprisonment and 3-year outcome in terms of re-incarceration and mortality. Design: Prospective, observational study (France, 2003-06)....
16.
Cacoub P, Ouzan D, Melin P, Lang J, Rotily M, Fontanges T, et al.
World J Gastroenterol
. 2008 Nov;
14(40):6195-203.
PMID: 18985810
Aim: To evaluate the impact of therapeutic education on adherence to antiviral treatment and sustained virological response (SVR) in a real-life setting in genotype 2/3 hepatitis C, as there are...
17.
Dussol B, Iovanna C, Rotily M, Morange S, Leonetti F, Dupuy P, et al.
Nephron Clin Pract
. 2008 Oct;
110(3):c185-94.
PMID: 18957869
Background: The purpose of this trial was to evaluate the efficacy of a low-animal-protein diet (LAPD) or a high-fiber diet (HFD) for the prevention of calcium nephrolithiasis recurrence. Methods: We...
18.
Wartelle-Bladou C, Arpurt J, Renou C, Pariente A, Pillon D, Nalet B, et al.
Gastroenterol Clin Biol
. 2006 May;
30(4):525-32.
PMID: 16733374
Objectives: To evaluate in naive patients with chronic hepatitis C 1- the efficacy and safety of one month interferon alpha (IFN-alpha) induction regimen; 2- the potential virological benefit of a...
19.
Halfon P, Bourliere M, Deydier R, Botta-Fridlund D, Renou C, Tran A, et al.
Am J Gastroenterol
. 2006 Mar;
101(3):547-55.
PMID: 16542291
Objectives: Fibrotest (FT) and Actitest (AT) are biochemical markers of fibrosis and activity for use as a non-invasive alternative to liver biopsy in patients with chronic hepatitis C virus (HCV)....
20.
Brunelle E, Rotily M, Lancon C, Goisset P, Piquet J, Lagadec G, et al.
Addiction
. 2005 Sep;
100(9):1377-8.
PMID: 16128733
No abstract available.